Congenica Revenue and Competitors
Estimated Revenue & Valuation
- Congenica's estimated annual revenue is currently $14.6M per year.
- Congenica's estimated revenue per employee is $155,000
Employee Data
- Congenica has 94 Employees.
- Congenica grew their employee count by -19% last year.
Congenica Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $1.2M | 248 | 7% | $460.5M | N/A |
#7 | $44.8M | 231 | 0% | $132.9M | N/A |
#8 | $7.6M | 49 | -37% | N/A | N/A |
#9 | $17.4M | 112 | 12% | N/A | N/A |
#10 | $334.6M | 1349 | 11% | £994.6M | N/A |
What Is Congenica?
Congenica is a digital health company with the world’s leading clinical decision support platform for accelerated genomic data interpretation. \n\nOur software enables genomic medicine by integrating genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients and their families.\n \nGenetic diseases are technically difficult to diagnose, and patients often spend years waiting for a diagnosis. We convert genomic data into actionable information, expediting the process through more efficient and accurate analysis. This supports healthcare professionals in providing patients with robust diagnoses and precise, personalised care. \n \nBorn out of pioneering research from the Wellcome Sanger Institute and the NHS, we are headquartered in Cambridge, UK, with a global footprint across the US and China. Our platform is validated by the pivotal Genomics England 100,000 Genomes Project and we are the exclusive clinical interpretation partner to the NHS Genomic Medicine Service.
keywords:N/A
N/A
Total Funding
94
Number of Employees
$14.6M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Congenica's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Professional Services Bioinformatics Consultant | Reveal Email/Phone |
2 | Staff Software Engineer | Reveal Email/Phone |
3 | Clinical Interpretation Service Lead & Clinical Scientist Oncology Lead | Reveal Email/Phone |
4 | Principal Data Architect | Reveal Email/Phone |
5 | Regional Director, UK, IRL and EMEA Strategic Accounts | Reveal Email/Phone |
6 | Chief Technology Officer | Reveal Email/Phone |
7 | Group CFO | Reveal Email/Phone |
8 | Lead Technical Project Manager | Reveal Email/Phone |
9 | Head Information Science | Reveal Email/Phone |
10 | Executive PA/ Office Coordinator | Reveal Email/Phone |
Congenica News
... (CGH) Software Market 2022 Global Future Forecasts Agilent Technologies, QIAGEN Digital Insights, Fabric Genomics, Congenica.
Congenica is a digital health company enabling the rapid analysis and interpretation of genomic data, empowering researchers and clinicians to...
Congenica launches Patient Advocacy and Engagement Advisory Board 14-01-2021 Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces the launch of a Patient Advocacy and Engagement Advisory Board. Working with th ...
Congenica launches Patient Advocacy and Engagement Advisory Board 14-01-2021 Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces the launch of a Patient Advocacy and Engagement Advisory Board. Working with th ...
Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid and accurate analysis of complex genomic data. The round was c ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.1M | 94 | 31% | N/A |
#2 | $14.6M | 94 | 27% | N/A |
#3 | $14.7M | 95 | -11% | N/A |
#4 | $15M | 96 | 71% | N/A |
#5 | $27.8M | 96 | 1% | N/A |